期刊文献+

孔源性视网膜脱离再手术病例的临床分析 被引量:2

Clinical analysis of reoperation of rhegmatogenous retinal detachment
下载PDF
导出
摘要 目的:分析孔源性视网膜脱离手术失败及术后脱离复发病例的原因、再手术术式选择及手术效果。方法:回顾性分析59例(60只眼)巩膜扣带术后视网膜未复位或脱离复发行再次手术治疗的孔源性网膜脱离病例。结果:第2次手术与第1次手术后出院视力相比差别无统计学意义(P>0.05)。第2次手术前增生性玻璃体视网膜病变(PVR)程度比第1次明显加重(P<0.05)。手术失败及早期视网膜脱离复发原因主要为PVR加重、新裂孔形成、原裂孔闭合不良。晚期复发原因可能为玻璃体基底部的牵拉。结论:视网膜脱离手术成功的关键是术前全面细致检查,术中确切封闭裂孔。巩膜扣带术仍然是再手术的主要术式。PVR严重时应行玻璃体切割术。绝大多数患者经再手术治疗后视网膜复位。 Objective To explore the causes, method selection and effects of reoperation about failed operation and recurrence of rhegmatogenous retinal detachment. Method We analyzed 59 cases (60 eyes) of RRD retrospectively, whose retina couldn't be retached or redetached after episcleral buckling surgery, and needed reoperation. Results The visual acuity showed no sigmficant differences after first and second surgery(P〉0.05), and the grades of proliferative vitreoretinopathy (PVR) before second surgery were significantly severer than that of first surgery (P〈0.05). The reasons that caused failed operation and early recurrent retinal detachment of RRD were progressive vitreoretinal traction with PVR, formation of new retinal breaks, reopening of original breaks, and the reasons that lead to later recurrent retinal redetachment were the vitreoretinal traction of vitreous bases. Conclusion The key to operative success are. searching ocular fundus carefully before operation and buckling all of the retinal breaks during operation. Episcleral buckling surgery is also the main method of reoperation. Vitrectomy should be applied when PVR is seriously. The majority of patients' retina could be retached after reoperation.
出处 《吉林医学》 CAS 2006年第8期861-863,共3页 Jilin Medical Journal
关键词 孔源性视网膜脱离 巩膜扣带术 PVR R.hegmatogenous retinal detachment Episcleral buckling surgery PVR
  • 相关文献

参考文献8

二级参考文献28

  • 1静文英,刘彩英.321例心脑血管病伴高脂血症患者血液流变学变化与中医辨证的关系[J].内蒙古中医药,1993,12(2):1-3. 被引量:20
  • 2张卯年,张雅红.53例玻璃体手术失败原因分析[J].中国实用眼科杂志,1995,13(12):727-729. 被引量:3
  • 3赖世隆 曹桂婵 等.中医证候的数理统计基础及血瘀证宏观辨证量化初探[J].中国医药学报,1988,3(6):27-27.
  • 4陈国林 李炜 等.通过肝阳上亢证的辨证探讨证的研究方法[J].中国医药学报,1988,3(5):67-67.
  • 5The Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology, 1983,90: 121-125.
  • 6Tseng W, Ramirez GC, Cortez RH, et al. Risk factors for proliferative vitreoretinopathy in eyes with primary rhegmatogenous retinal detachment and no previous vitreoretinal surgery. Invest Ophthalmol Vis Sci, 2001,42 (Suppl) : 431.
  • 7Wiedemann P, Hilgers RD, Bauer P, et al. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a muhicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol, 1998,126:550-559.
  • 8Asaria RH, Kon CH, Bunce C, et al. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trial. Ophthalmology, 2001,108:1179-1183.
  • 9Cowley M, Conway BP, Campochiaro PA, et al. Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol, 1989,107:1147-1151.
  • 10Nagasaki H, Shinagawa K, Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res, 1998, 17: 77-98.

共引文献19

同被引文献42

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部